Trial Profile
Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- 24 Apr 2012 New trial record